BillionToOne to Report Second Quarter 2026 Financial Results on August 5, 2026
核心洞察
BillionToOne (搜索), Inc. (NASDAQ: BLLN) will release its second quarter 2026 financial results after market close on Wednesday, August 5, 2026.
The molecular diagnostics company will host a conference call at 1:30pm Pacific Time / 4:30pm Eastern Time the same day to discuss results.
BillionToOne (搜索)'s proprietary Quantitative Counting Templates (QCT) platform enables single-molecule DNA counting for accurate molecular diagnostic testing.
BillionToOne (搜索), Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company headquartered in Menlo Park, California, announced that it plans to release its financial results for the second quarter ended June 30, 2026, after the market close on Wednesday, August 5, 2026. The company will host a conference call to discuss its financial results at 1:30pm Pacific Time / 4:30pm Eastern Time the same day.
The announcement, issued July 15, 2026, underscores the company's continued engagement with the investment community as it advances its mission to create powerful and accurate tests that are accessible to all.
Conference Call and Webcast Details
Analysts planning to participate in the conference call should register before the 1:30pm Pacific Time / 4:30pm Eastern Time start. A live and archived webcast for interested listeners will be available on the "Events" page of BillionToOne (搜索)'s investor relations website at https://investors.billiontoone.com/.
Company Platform and Technology
BillionToOne (搜索) describes itself as a next-generation molecular diagnostics company. The company's patented Quantitative Counting Templates (QCT) molecular counting platform is described as the only multiplex technology that can accurately count DNA molecules at the single-molecule level.
In a separate announcement dated September 2, 2026, the company further detailed its proprietary single-molecule next-generation sequencing (smNGS) platform, which it characterizes as the only multiplex technology that can detect and precisely quantify genetic targets at the physical limit of detection, down to the single DNA molecule. Enabled by Quantitative Counting Templates (QCTs), the platform quantifies disease-related DNA fragments with single base-pair resolution, providing absolute quantification.
Upcoming Investor Engagement
In addition to its quarterly financial reporting, BillionToOne (搜索) announced that company management will participate in the Wells Fargo 21st Annual Healthcare Conference. Management will participate in a fireside chat from 2:15pm to 2:50pm Eastern Time on Wednesday, September 9, 2026. A live and archived webcast will be available on the "Events & Presentations" page of BillionToOne's investor relations website at https://investors.billiontoone.com/news-events/events-presentations.